GOODRX HOLDINGS INC-CLASS A (GDRX) Fundamental Analysis & Valuation

NASDAQ:GDRX • US38246G1085

2.35 USD
+0.07 (+3.07%)
At close: Mar 9, 2026
2.35 USD
0 (0%)
Pre-Market: 3/10/2026, 7:19:49 AM

This GDRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

GDRX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. While GDRX has a great profitability rating, there are some minor concerns on its financial health. GDRX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make GDRX suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. GDRX Profitability Analysis

1.1 Basic Checks

  • In the past year GDRX was profitable.
  • GDRX had a positive operating cash flow in the past year.
  • In multiple years GDRX reported negative net income over the last 5 years.
  • In the past 5 years GDRX always reported a positive cash flow from operatings.
GDRX Yearly Net Income VS EBIT VS OCF VS FCFGDRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • The Return On Assets of GDRX (2.17%) is better than 82.86% of its industry peers.
  • With an excellent Return On Equity value of 4.94%, GDRX belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
  • GDRX has a Return On Invested Capital of 5.97%. This is amongst the best in the industry. GDRX outperforms 88.57% of its industry peers.
Industry RankSector Rank
ROA 2.17%
ROE 4.94%
ROIC 5.97%
ROA(3y)0.93%
ROA(5y)-0.17%
ROE(3y)2.01%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A
GDRX Yearly ROA, ROE, ROICGDRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • With an excellent Profit Margin value of 3.82%, GDRX belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • With an excellent Operating Margin value of 10.98%, GDRX belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GDRX has grown nicely.
  • GDRX has a Gross Margin of 92.77%. This is amongst the best in the industry. GDRX outperforms 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of GDRX has remained more or less at the same level.
Industry RankSector Rank
OM 10.98%
PM (TTM) 3.82%
GM 92.77%
OM growth 3Y71.11%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.46%
GM growth 5Y-0.39%
GDRX Yearly Profit, Operating, Gross MarginsGDRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

5

2. GDRX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GDRX is destroying value.
  • GDRX has less shares outstanding than it did 1 year ago.
  • GDRX has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for GDRX has been reduced compared to a year ago.
GDRX Yearly Shares OutstandingGDRX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
GDRX Yearly Total Debt VS Total AssetsGDRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • GDRX has an Altman-Z score of 0.32. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.32, GDRX is in line with its industry, outperforming 51.43% of the companies in the same industry.
  • GDRX has a debt to FCF ratio of 5.20. This is a neutral value as GDRX would need 5.20 years to pay back of all of its debts.
  • GDRX's Debt to FCF ratio of 5.20 is in line compared to the rest of the industry. GDRX outperforms 60.00% of its industry peers.
  • GDRX has a Debt/Equity ratio of 0.78. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
  • GDRX has a Debt to Equity ratio of 0.78. This is amonst the worse of the industry: GDRX underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 5.2
Altman-Z 0.32
ROIC/WACC0.6
WACC9.94%
GDRX Yearly LT Debt VS Equity VS FCFGDRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M 800M

2.3 Liquidity

  • GDRX has a Current Ratio of 2.61. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of GDRX (2.61) is better than 62.86% of its industry peers.
  • A Quick Ratio of 2.61 indicates that GDRX has no problem at all paying its short term obligations.
  • The Quick ratio of GDRX (2.61) is better than 62.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 2.61
GDRX Yearly Current Assets VS Current LiabilitesGDRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. GDRX Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.06% over the past year.
  • Measured over the past 5 years, GDRX shows a small growth in Earnings Per Share. The EPS has been growing by 5.27% on average per year.
  • The Revenue has been growing slightly by 0.57% in the past year.
  • GDRX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.67% yearly.
EPS 1Y (TTM)6.06%
EPS 3Y5.27%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)0.57%
Revenue growth 3Y1.3%
Revenue growth 5Y7.67%
Sales Q2Q%-1.91%

3.2 Future

  • Based on estimates for the next years, GDRX will show a very strong growth in Earnings Per Share. The EPS will grow by 26.73% on average per year.
  • The Revenue is expected to grow by 2.85% on average over the next years.
EPS Next Y4.89%
EPS Next 2Y10.97%
EPS Next 3Y12.61%
EPS Next 5Y26.73%
Revenue Next Year-2.7%
Revenue Next 2Y1.43%
Revenue Next 3Y2.95%
Revenue Next 5Y2.85%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GDRX Yearly Revenue VS EstimatesGDRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
GDRX Yearly EPS VS EstimatesGDRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8

9

4. GDRX Valuation Analysis

4.1 Price/Earnings Ratio

  • GDRX is valuated cheaply with a Price/Earnings ratio of 6.71.
  • Based on the Price/Earnings ratio, GDRX is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.45, GDRX is valued rather cheaply.
  • The Price/Forward Earnings ratio is 6.40, which indicates a rather cheap valuation of GDRX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 94.29% of the companies listed in the same industry.
  • GDRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.65, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.71
Fwd PE 6.4
GDRX Price Earnings VS Forward Price EarningsGDRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GDRX is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 88.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.57
EV/EBITDA 5.97
GDRX Per share dataGDRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • GDRX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of GDRX may justify a higher PE ratio.
  • GDRX's earnings are expected to grow with 12.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)N/A
EPS Next 2Y10.97%
EPS Next 3Y12.61%

0

5. GDRX Dividend Analysis

5.1 Amount

  • GDRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

GDRX Fundamentals: All Metrics, Ratios and Statistics

GOODRX HOLDINGS INC-CLASS A

NASDAQ:GDRX (3/9/2026, 8:07:57 PM)

Premarket: 2.35 0 (0%)

2.35

+0.07 (+3.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners54.5%
Inst Owner Change6.02%
Ins Owners11.41%
Ins Owner Change12.95%
Market Cap805.04M
Revenue(TTM)796.85M
Net Income(TTM)30.44M
Analysts71.43
Price Target4.65 (97.87%)
Short Float %11.33%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.52%
Min EPS beat(2)-13.38%
Max EPS beat(2)-3.65%
EPS beat(4)0
Avg EPS beat(4)-8.7%
Min EPS beat(4)-13.38%
Max EPS beat(4)-3.65%
EPS beat(8)1
Avg EPS beat(8)-7.27%
EPS beat(12)5
Avg EPS beat(12)-0.32%
EPS beat(16)9
Avg EPS beat(16)11.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.2%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)-1.19%
Revenue beat(4)0
Avg Revenue beat(4)-1.83%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.87%
Revenue beat(12)0
Avg Revenue beat(12)-2.02%
Revenue beat(16)2
Avg Revenue beat(16)-1.42%
PT rev (1m)0%
PT rev (3m)-10.39%
EPS NQ rev (1m)-17.38%
EPS NQ rev (3m)-17.29%
EPS NY rev (1m)-16.77%
EPS NY rev (3m)-18.17%
Revenue NQ rev (1m)-4.57%
Revenue NQ rev (3m)-4.67%
Revenue NY rev (1m)-5.11%
Revenue NY rev (3m)-5.41%
Valuation
Industry RankSector Rank
PE 6.71
Fwd PE 6.4
P/S 1.01
P/FCF 8.57
P/OCF 4.79
P/B 1.31
P/tB N/A
EV/EBITDA 5.97
EPS(TTM)0.35
EY14.89%
EPS(NY)0.37
Fwd EY15.62%
FCF(TTM)0.27
FCFY11.66%
OCF(TTM)0.49
OCFY20.86%
SpS2.33
BVpS1.8
TBVpS-0.05
PEG (NY)1.37
PEG (5Y)N/A
Graham Number3.76
Profitability
Industry RankSector Rank
ROA 2.17%
ROE 4.94%
ROCE 7.56%
ROIC 5.97%
ROICexc 7.71%
ROICexgc 26.32%
OM 10.98%
PM (TTM) 3.82%
GM 92.77%
FCFM 11.78%
ROA(3y)0.93%
ROA(5y)-0.17%
ROE(3y)2.01%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y49.69%
ROICexgc growth 5YN/A
ROICexc growth 3Y64.86%
ROICexc growth 5YN/A
OM growth 3Y71.11%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.46%
GM growth 5Y-0.39%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 5.2
Debt/EBITDA 2.8
Cap/Depr 86.86%
Cap/Sales 9.29%
Interest Coverage 2.14
Cash Conversion 97.22%
Profit Quality 308.43%
Current Ratio 2.61
Quick Ratio 2.61
Altman-Z 0.32
F-Score6
WACC9.94%
ROIC/WACC0.6
Cap/Depr(3y)79.94%
Cap/Depr(5y)88.33%
Cap/Sales(3y)8.53%
Cap/Sales(5y)7.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.06%
EPS 3Y5.27%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y4.89%
EPS Next 2Y10.97%
EPS Next 3Y12.61%
EPS Next 5Y26.73%
Revenue 1Y (TTM)0.57%
Revenue growth 3Y1.3%
Revenue growth 5Y7.67%
Sales Q2Q%-1.91%
Revenue Next Year-2.7%
Revenue Next 2Y1.43%
Revenue Next 3Y2.95%
Revenue Next 5Y2.85%
EBIT growth 1Y32.63%
EBIT growth 3Y73.33%
EBIT growth 5YN/A
EBIT Next Year18.11%
EBIT Next 3Y10.62%
EBIT Next 5Y8.31%
FCF growth 1Y-17.32%
FCF growth 3Y0.82%
FCF growth 5Y-0.34%
OCF growth 1Y-8.69%
OCF growth 3Y4.58%
OCF growth 5Y5.04%

GOODRX HOLDINGS INC-CLASS A / GDRX FAQ

Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?

ChartMill assigns a fundamental rating of 6 / 10 to GDRX.


What is the valuation status for GDRX stock?

ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.


What is the profitability of GDRX stock?

GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 7 / 10.


What is the earnings growth outlook for GOODRX HOLDINGS INC-CLASS A?

The Earnings per Share (EPS) of GOODRX HOLDINGS INC-CLASS A (GDRX) is expected to grow by 4.89% in the next year.